discovery News & Events

April 17, 2007 discovery biosciences announces  its involvement with BioSyndicate, a new portal focused on helping you find just the right life-science industry specialists for your consulting or contracting needs.

March 20, 2007 You are cordially invited to join Microsoft, industry experts and your peers as Microsoft presents BioIT Forum, April 19, 2007 in Mountain View CA.

May 1, 2006 discovery biosciences joins BioIT Alliance.

November 1, 2003 discovery biosciences announces  discoverySource, a suite of technology source materials available in text and SQL-ready formats. 

October 1, 2002 discovery biosciences announces partnership with Tooned In, Inc. to provide graphic services.

June 1, 2002 discovery biosciences announces partnership with Pivotalinfo to provide IP and market research services.

October 1, 2001 discovery biosciences announces the release of jot 3.0

September 19, 2001 NW MIT Enterprise Forum Presents:

The Next Disruptive Technology - Bio-informatics: The Convergence of Info Tech and Bio Tech.

May 20-22, 2001 5th International Biotech & Infotech Summit

March 27, 2001 Discovery 2001: Innovative Advances in Drug Discovery

February 20, 2001 discovery biosciences announces the release of jot 2.0.

January 10, 2001 discovery biosciences announces the release of multiFPC 1.2.

 

April 17, 2007  discovery biosciences announces its involvement with BioSyndicate

 

discovery biosciences announces its involvement with BioSyndicate.  BioSyndicate is a new alliance of life-science specialists offering consulting and/or contracting services  The BioSyndicate portal will help potential clients and service providers find each other.  The range of expertise represented will broadly reflect industry needs, such as bio/chemoinfomatics services, marketing and marketing analysis, strategic planning, technology/IP assessment and development, media preparation, etc..  Details will be coming soon.  However, if you provide independent services to our industry and are interested in finding learning more about becoming a member, please contact us.

.

Top of page

 

March 20, 2007 You are cordially invited to join Microsoft, industry experts and your peers as Microsoft presents BioIT Forum, April 19, 2007 in Mountain View CA.

 

We have put together an intriguing agenda featuring our special guest, Dr. Tim Hunkapiller, presenting “The $1,000 Genome – What Will It Mean, What Will It Take, and When Will it Happen?”. Dr. Hunkapiller has been a pioneering presence in computational biotechnology since its infancy 30 years ago and is co-inventor of the largest selling analytical research instrument in the world: the Perkin Elmer/Applied Biosystems DNA sequencer.

 

We will also present a number of Microsoft technologies that are directly relevant to Life Science discovery and development. This event is an opportunity to understand how the current generation of Microsoft technology can accelerate the discovery process. Seating is limited so please register early to guarantee your place.

Top of page

 

 

May 1, 2006  discovery biosciences joins the BioIT Alliance.

 

discovery biosciences announces it's joining Microsoft's BioIT Alliance.  The Alliance is a group of organizations working together to realize the potential of personalized medicine. The Alliance unites the pharmaceutical, biotech, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to speed the pace of discovery in the life sciences.  Members are particularly interested in the development capabilities of Microsoft platforms such as Office and Sharepoint.   full story...

Top of page

 

 

November, 2003  discovery biosciences announces  discoverySource

 

discovery biosciences announces discoverySource, a suite of technology source materials available in text and SQL-ready formats.  These will be primarily text-based corpora that can be searched and mined directly with many commercial tools, including our own discoveryView text mining system.  Our first release is the complete text source of US patents since 1976 in the least expensive, cleanest and most easily accessible format available anywhere - even the patent office.  Up until now, these data have been available through the US Patent Office in a hodgepodge of  tape and disk formats depending on the years included.  Most patent search companies no longer provide external copies, requiring expensive on-line service charges.  This makes it nearly impossible to develop and validate new mining algorithms on these critical data.  We have now taken these data and provide a common, readable format ready for import into an SQL-based system or used as flat text delivered on a single Firewire and/or USB2.0 hard disk drive, readable on essentially any computer by just plugging it in.  We have also "cleaned" the data to better insure consistency in dates and references.  Updates will be available as well.  We deliver this resource at a fraction of the cost that one would pay the USPTO for just the raw text (and un-cleaned) on multiple tapes (DLT) and DVDs.  We use this same resource in our discoveryView text mining system and are making it available here for those with their own interests and needs in large text corpora or the patent database in particular.  We will be adding new source materials in the near future.  Please email or call us for pricing and delivery schedules.  full story...

Top of page

 

October 1, 2002  discovery biosciences announces partnership with Tooned In

 

discovery biosciences and Tooned In Inc.announce a partnership to provide animated graphics for life science researchers and organizations.  Tooned In is an animation company in Seattle, WA expert in traditional 2D techniques as well as computer-aided 3D modeling and animation and web-friendly delivery methods such as Flash.  They develop a wide range of entertainment and gaming graphics as well as technical materials.  Combining this expertise with the technical and scientific insight of discovery biosciences will allow us to provide technically accurate, visually engaging and effective illustration of scientific and technical ideas as well as marketing, training and educational materials.  The style of illustration can range from cartoony all the way to realistic.  We can provide affordable solutions for the single researcher needing to illustrate a novel scientific discovery or an entire marketing and educational portfolio for a life science company.  full story... 

Top of page

 

June 1, 2002  discovery biosciences announces partnership with Pivotalinfo

 

discovery biosciences announces a partnership with Pivotalinfo, LLC to provide IP and market research services.  Pivotalinfo is a Washington-based company specializing in intellectual property prior art research as well as market intelligence gathering.  Their clients include multiple Fortune 500 corporations and independent researchers and authors.  Combining their expertise and knowledge of search techniques and intelligence data sources with discovery biosciences' experience and knowledge of life science technologies, chemistry,  biology and computational science will provide a powerful new resource for any researcher or organization that needs to know what is known in their domain of interest.  full story...

Top of page

 

October 1, 2001  discovery biosciences announces the release of jot 3.0

discovery biosciences announces the release of jot 3.0jot is the first commercially supported dot matrix viewer capable of supporting whole genome comparisons.  It incorporates many unique scaling and graphic tools as well as acceleration by the Paracel Genematcher.  With Version 3.0, jot now supports the use of Blast for those with no Genematcher resource.  This greatly increases the accessibility of jotBlast can be directly launched from jot, or results from other Blast servers can be imported.  Version 3.0 also includes several improvements to 2.0.  A demonstration version of jot can be downloaded for free.  full story... 

Top of page

September 19, 2001 - 5:00 p.m.

NW MIT Enterprise Forum Presents:

The Next Disruptive Technology - Bio-informatics: The Convergence of Info Tech and Bio Tech
Location : Bellevue Hyatt Regency, 900 Bellevue Way NE

As industry giants like IBM and Compaq pour $100 million each into research projects on biotechnology, many questions are raised. What are the practical applications? How will it improve our quality of life? What does the hybrid of information technology and biotechnology — called bioinformatics — mean for our economy, for the Pacific Northwest and for you in particular? 

On September 19th, the MIT Enterprise Forum and the Washington Biotechnology and Biomedical Association will assemble a panel of experts to offer pivotal perspectives on this fast-emerging field. Panelists include: 

Moderator: 
Bruce Carter, President and CEO, Zymogenetics 

Panelists: 
Jeff Augen, Director - Business Strategy Life Sciences, Blue Gene, IBM 
Tim Hunkapiller, President and CSO, Discovery Biosciences 
Steve Friend, President, Rosetta Inpharmatics 
Robert T. Nelsen, Managing DIrector, Arch Venture Partners

Patrick O'Hara, VP Bioinfomratics, Zymogenetics

 

Top of page

May 20-22, 2001

Late last June, Bio/Pharma industry leaders George Poste, Leroy Hood, David Kingsbury, Ed Penhoet, Carl Feldbaum and a couple hundred other executives got together for a "little" announcement -- the completion of the mapping of the Human Genome. The announcement was but one note at the 4th International Biotech & Infotech Summit as the attendees were all deeply engaged in discussing subjects that will generate future historic milestones... 

Wonder what they will be discussing May 20-22, 2001 at UCSF's Laurel Heights Campus?  Perhaps you should register right now... after all, "Biotech Evolutions" move very quickly -- and so should you.  Topics and confirmed participants include: 

TAMING THE TORRENT OF GENOMIC DATA: How Computer Science and Math are Shaping a "New Biology"
David Kingsbury, Ph.D., Chairman of the Board & Chief Executive Officer, Discovery Biosciences Corporation
Peter J. Farley, M.D., President & Chief Executive Officer, BeoWulf
David Haussler, Ph.D., Associate Director, California Institute for Bioengineering, Biotechnology & Quantitative Biomedical Research
Russ B. Altman, M.D., Ph.D. , Director, Biomedical Infomatics Training Program Associate Professor of Medicine, Stanford University


BIOTECH'S NEXT GREAT ACT: Making a Business of Proteomics
Tim Hunkapiller, Ph.D., Co-founder, President & Chief Scientific Officer, Discovery Biosciences
Donald Kennedy, Ph.D., Panel Chairman, Editor-in-Chief, Science Magazine
Rudi Aebersold, Ph.D., Professor & Co-founder, Institute for Systems Biology
Raj Parekh, Ph.D., Chief Scientific Officer, Oxford GlycoSciences
Lawrence K. Cohen, Ph.D., Chief Executive Officer, Zyomyx

Check the agenda and register --> http://www.biotechsummit.com. This year's sponsors include: The Nasdaq Stock Market; Science Magazine; Alloy Ventures with: Sofinnova Ventures; Techno Venture Management and Earlybird Ventures; California Healthcare Institute, and BIO.

Top of page

 

March 27, 2001 at 12:00 PM

 

Discovery 2001: Innovative Advances in Drug Discovery

March 26-29th , 2001 in San Diego, CA.

Sponsored by International Institute of Research. 

How IT Can Enable Cutting Edge Drug Discovery

Steve Chin

Worldwide Pharmaceutical Industry Manager, Microsoft Corp.

Tim Hunkapiller

President and Chief Scientific Officer Discovery Biosciences Corporation

Information technology is being incorporated into the drug discovery process by many healthcare organizations.  This session explores a joint alliance between Microsoft and one of their lead discovery partners.  A successful business model has been developed by Microsoft which has been incorporated into their collaboration process.  Discussed are elements of information technology that can facilitate drug discovery and maximizes the outcome benefits.

 

Top of page

February 20, 2001  discovery biosciences announces the release of jot 2.0

discovery biosciences announces the release of jot 2.0jot is the first commercially supported dot matrix viewer capable of supporting whole genome comparisons.  It incorporates many unique scaling and graphic tools as well as acceleration by the Paracel Genematcher.  It has recently been employed to cross compare all human chromosomes from the Celera genome project..  Version 2.0 includes several improvements to 1.0, including:  support for multiple, pooled comparisons, export of graphics files, more sophisticated trace analysis, more refined filtering capabilities, stronger annotation support and graphics and more flexible scaling options.  A demonstration version of jot can be downloaded for free.

Top of page

January 10, 2001  discovery biosciences announces release of multiFPC 1.2

discovery biosciences announces the release of multiFPC 1.2multiFPC 1.2 is the first generally available tool for large-scale clone mapping using four-color fluorescent data from automated sequencers.  Although based on the FPC program from the Sanger Institute, multiFPC 1.2 represents a significant advance in both ease of analysis and statistical robustness.  It also greatly facilitates the design of large-scale mapping operations.  Version 1.2 now includes support for single-base extension labeling in four or more colors.  The current version is free for download.  Fully supported commercial versions are available.  full story...

Top of page

Copyright © Discovery Biosciences Corporation, 2007